Clinical guidelines on urinary tract infection in women were released in May 2019 by the American Urological Association (AUA), Canadian Urological Association (CUA), and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU).
The American Urological Association (AUA) has issued its first guideline for the diagnosis and treatment of uncomplicated recurrent urinary tract infections (UTIs), emphasizing the importance of cultures and antibiotic stewardship.
Women presenting with recurrent lower urinary tract infections (rUTI) should undergo a complete patient history and pelvic examination.
A diagnosis of rUTI must be based on documented positive urine culture results in association with prior symptomatic episodes.
An initial urine specimen that may be contaminated should prompt a repeat urine study; collection of a catheterized specimen should be considered.
Index patients presenting with rUTI should not routinely undergo upper tract imaging and cystoscopy.
Before beginning treatment in patients with rUTI, urinalysis, urine culture, and sensitivity should be performed for each symptomatic acute cystitis episode.
Select patients with rUTI with acute episodes may be offered patient-initiated treatment (self-start treatment) while urine culture results are pending.
Surveillance urine testing, including urine culture, should not be performed in asymptomatic patients with rUTI.
Asymptomatic bacteriuria should not be treated.
Symptomatic UTIs in women should be treated with first-line therapy (ie, nitrofurantoin, TMP-SMX, fosfomycin) and should depend on local antibiogram.
The duration of antibiotic therapy for rUTI in patients with acute cystitis episodes should be as short as is reasonable (typically no longer than 7 days).
rUTIs in patients with acute cystitis that has shown resistance to oral antibiotics on urine culture may be treated with culture-directed parenteral antibiotics for as short a course as is reasonable (typically no longer than 7 days).
After discussing the risks, benefits, and alternatives, antibiotic prophylaxis may be prescribed to reduce the risk of future UTIs in women of all ages previously diagnosed with UTI.
Cranberry prophylaxis may be offered to women with rUTI.
Posttreatment urinalysis or urine culture to test for cure should not be performed in asymptomatic patients.
UTI symptoms that persist after antimicrobial therapy should prompt repeat urine culture to guide further treatment.
Vaginal estrogen therapy with no contraindications should be recommended to perimenopausal and postmenopausal women with rUTIs to reduce the risk of future UTI.
For more information, please go to Urinary Tract Infection (UTI) and Cystitis (Bladder Infection) in Females.
For more Clinical Practice Guidelines, please go to Guidelines.
Medscape © 2019 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Urinary Tract Infection in Women Clinical Practice Guidelines (2019) - Medscape - Jun 03, 2019.